We have previously shown that oncogenic GGA to GAA mutations in codon 12 of the Ha-ras-1 gene arise spontaneously during normal development of the mammary epithelium of female Fischer 344 (F344) rats. Our result further demonstrated that the vast majority of nitrosomethylurea (NMU)-induced rat mammary tumors with Ha-ras-1 oncogenes arose from these pre-existing mutants. We therefore investigated whether Ha-ras-1 mutants acquired a selective growth advantage in vivo in the absence of NMU exposure. Our results indicated that between the ages of 50 and 570 days, the total number mammary epithelial cells per rat increased ~5 fold (from 3.7 X10 7 to 1.8X10 8 cells), while the average number of Ha-ras-1 mutants per rat increased -25 fold (from 160 to 4000 cells). Thus, the mutants acquired a measurable (5-fold) growth advantage in vivo. To determine if the growth of these mutants contributed to spontaneous mammary carcinogenesis, we measured Ha-ras-1 mutant fractions in 26 tumors from untreated F344 rats. The assay failed to detect Ha-ras-1 mutant fractions higher than 10~3, indicating that in the mammary epithelium, the activating mutation of the Ha-ras-1 gene is a conditional oncomutation, whose oncogenic potential is realized only under certain specific physiological conditions, such as exposure to a carcinogenic dose of NMU exposure.
The life time incidence of spontaneous mammary tumors among laboratory rats ranges from 40% for Fischer 344 to over 80% for Buff/N rats (1,2). While a large number of studies have focused on molecular changes in chemically induced rat mammary tumors (3, 4) , the molecular mechanisms underlying the spontaneous carcinogenesis remain largely unknown. Utilizing a highly sensitive mismatch amplification mutation assay (MAMA*; 5), we have previously shown that specific oncogenic Ha-ras-1 gene mutations (G to A transition at the 12th codon) arose spontaneously during the normal development of the mammary glands in female Fischer 344 rats (6) . We further demonstrated that a single carcinogenic dose of NMU resulted in the selective outgrowth of these preAbbreviations: NMU, nitrosomethylurea; MAMA, mismatch amplification mutation assay; dNTP, 2'-deoxynucleoside 5'-triphosphates; DMBA, dimethylbenz [a] anthracene.
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existing Ha-ras-1 mutants, which eventually gave rise to the vast majority of tumors harboring Ha-ras-1 oncogenes. This nitrosomethylurea (NMLT)-induced outgrowth of mutants was not observed in liver of the same rats (6) . Together these results suggested that the 12th codon Ha-ras-1 mutation might be a conditional oncomutation whose oncogenic potential is only expressed in certain cell types and can be unveiled only under certain conditions. In the present study, we tested this hypothesis by determining whether cells carrying the spontaneous Ha-ras-1 mutations acquired a growth advantage under physiological conditions in vivo and whether they contributed to spontaneous mammary tumorigenesis.
We utilized a MAMA specific for the codon 12 GGA to GAA in Ha-ras-1 to measure the mutant fractions in the macroscopically normal mammary tissue from 570-day old rats and in spontaneous mammary lesions collected from 26-30-month-old rats. Virgin female Fischer rats were obtained at 45 days of age (Charles River Laboratory, MA) and were fed ad libitum. Seven animals were killed at 570 days of age. To investigate the distribution of Ha-ras-1 mutants within the mammary glands of a rat and to increase the likelihood of detecting rare mutants, mammary tissue from each animal was divided into five sectors that yielded an equivalent number of epithelial cells (5, 6) . Cell preparations highly enriched for epithelial cells were obtained using previously reported protocols (7). In our hands, ~80% of the cells isolated by this procedure consisted of mammary epithelial cells (6) . Cell were counted using a Coulter Counter 7 ™ (Coulter Electronics, Inc., Healeah, FL) prior to isolation of genomic DNA (8, 9) .
The MAMA reaction was performed as described elsewhere (5). Briefly, each reaction mixture consisted of 5 (ig of sample genomic DNA (~1.5X 10 6 copies of the Ha-ras-1 gene), 300 nM each of the mutant specific mismatch primer PAA (5'-CTTGTGGTGGTGGGCGCTGAA-3') and the Pmnl2 (5'-ACTCGTCCACAAAATGGTTC-3') primer, 37 U. M of each 2'-deoxynucleoside 5'-triphosphates (dNTP's), 1 |il of a 32 P-ATP (3000 Ci/mmol), and 10 \il of glycerol in 100 ul of PCR buffer (10 mM Tris-HCl, pH 8.4, 50 mM KC1, 2.25 mM MgCl 2 ). Approximately 1.7 units of native Taq polymerase were added and the mixture was subjected to 35 cycles of a two-step PCR consisting of 1 min incubation at 94°C followed by 1 min incubation at 50°C. A 10-ul aliquot from each MAMA reaction mixture was analysed on a 7% polyacrylamide gel (acrylamide/bis ratio = 38/2), and the amount of radioactivity present as the mutant specific 74 bp amplification product was measured by PhosphorImager™ analysis (Molecular Dynamics, Sunnyvale, CA). The amplification of the 128 bp product in all samples when utilizing the control primers (PI; 5'-CCTGGTTTGGCA-ACCCCTGT-3' and Pmnl2; 5'-ACTCGTCCACAAAATGG-TTC-3') indicated that all DNA samples could be amplified with comparable efficiencies.
As with any quantitative assay, there is some variability in the output among independent replicates of the same sample, affecting both the quantitative controls ( Figure 1 ) and actual tissue samples. Every sample was assayed on at least two separate occasions with concurrent, quantitative control sets which were prepared by mixing 5 | Xg of genomic DNA isolated from the liver tissue of an untreated Fischer 344 rat with varying amounts (0, 15, 150 or 1500 copies) of a tumor DNA containing the specific G to A mutation. An example of one such assay used for quantitative analysis is presented in Figure 2 . After quantitating data from independent experiments, we determined the mean of the signal measured from the 74 bp product for a given sample and compared it to the mean signal measured from the 74 bp of the concurrent negative controls (e.g. see 0 control in Figure 2 ) (5,6). Student's Mest was used to determine if the mean obtained for individual samples was greater than the mean of the signal obtained for the negative control at the 95% confidence limit (P < 0.05) (13) . The latter definition was rigorously applied in determining if a tissue or tissue sector contained a number of mutant alleles that was significantly above the background.
On average, we were able to isolate -l.SXIO 8 epithelial cells from the mammary glands of 570-day-old rats. The same procedure yielded ~3.7X10 7 epithelial cells from 50-day-old rats (6), indicating that there was an increase of ~5-fold in the number of mammary epithelial cells during this 520-day period. The results of MAMAs performed on epithelial cells isolated from macroscopically normal mammary tissue of seven, untreated, 570-day-old rats is shown in Figure 2 . Twelve of 34 samples (one sample was lost during preparation) reproducibly generated signals that were significantly above the background (P < 0.05) and were therefore scored as positives for the Ha-ras-1 mutation. Mutant fractions were estimated using multiple standard curves generated from the quantitative control sets, including those shown in each autoradiogram ( Figure 2 , Table I ). The Ha-ras-1 mutant fractions varied from 2X 10~5 to 2X1(T\ representing 720-7200 mutant cells per sector (Table I) . Between the ages of 50 (6) and 570 days, the average number of Ha-ras-1 gene mutants per animal increased -25-fold, from 160 to 4000 copies (Table II) . If we assume that this increase was not the result of the mutant alleles being amplified in the mutant cells, then these results suggested that the number of mutant cells increased ~25-fold. Since the total number of mammary epithelial cells increased by ~5-fold during the same period (Table III) , our results indicated that the Ha-ras-1 mutants acquired, at most, a 5-fold growth advantage in vivo over a 520-day period.
To determine if this growth advantage contributed to tumorigenesis, we measured the Ha-ras-1 mutant fractions in spontaneous mammary tumors from virgin female Fischer 344 rats between the ages of 26-30 months (National Institute of Aging, Bethesda, MD). A total of 26 mammary lesions were collected from 10 animals. Some of the larger lesions (S1T4, S2T2, S3T2, S3T4, S7T1; Table II, Figure 3) were comprised of regions that were distinguishable from one another at a gross level due to coloration or texture (data not shown). These regions were separated and assayed independently for the presence of Ha-ras-1 gene mutations. Histopathological analysis of each sample was carried out by Dr R.Cardiff (UCSD). All tumors were diagnosed as benign lesions, most of which were classified as either fibroadenomas or benign hyperplasias (Table II) .
The results of the MAMA indicated that in five of 26 spontaneous mammary lesions, the signals measured from the 74 bp mutant specific amplification product were significantly above the background signals ( Figure 3 , Table II ). The mutant fractions for the specific mutation among these lesions ranged from 4.5X10" 5 to 4.5X10" 4 . Since tumors are clonal in their origin (11), any lesion originating from a mutant cell would be expected to carry the Ha-ras-1 oncogene in the majority of the cells within the lesion, unless the mutant allele was selected against at later stages of tumorigenesis. Since the 12th codon G to A mutation in Ha-ras-1 gene has been shown to contribute to neoplastic transformation in a number of systems (3, 4, 12) , it is highly unlikely that the cells having the Ha-ras-1 mutations would be selected against during spontaneous tumorigenesis. Thus, the low mutant fractions observed among the spontaneous tumors indicated that these tumors did not arise from cells with pre-existing Ha-ras-1 mutations, rather the mutations arose at later stages of tumor growth. This notion is further supported by the observation that grossly distinguishable regions within lesions S1T4 and S3T4 were scored either positive or negative for the mutation (Figure 3 , Table II) .
Unlike spontaneous mammary lesions (Table IT) , up to 90% of NMU-induced lesions are classified as malignant (10, 13, 14) . It has also been shown that at lower doses of NMU, most of the mammary carcinomas carry the specific G to A mutation at the 12th codon of the Ha-ras-1 gene (14) . The conspicuous absence of Ha-ras-1 gene mutant fractions above 10~3 among spontaneous lesions, and the striking differences in the histopathologies of NMU-induced versus spontaneous mammary lesions indicated that different molecular pathways of pathogenesis are selected by NMU exposure and spontaneous tumorigenesis. It is thus likely that under normal physiological conditions, a growth advantage might be imparted to cells harboring other, as yet undefined, oncomutations or epigenetic changes that promote the pathogenesis of benign lesions. By contrast, exposure to NMU created a condition which allowed the outgrowth of cells with pre-existing Ha-ras-1 oncogenes, which then contribute to the pathogenesis of malignant lesions.
Previous studies have demonstrated that different selective pressures can influence the kinds of mutations later observed in transformed cells (15) . In the mouse skin tumor model, 500-1 500-2 500-3 500-4 4 and 10~3 as indicated. The 128 bp fragment represents the control PCR amplified product which was generated with regular PCR and is used to compare the relative amplification efficiencies among different samples (see text). The 74 bp fragment represents the specific amplification product of the transforming allele using the mismatch primer. The amount of radioactivity incorporated into each band was measured by Phospholmager (Molecular Dynamics). Each sample was assayed on at least two separate occasions, and ' + ' denotes those samples with a Ha-ras-1 mutant number that was significantly above the 0 mutant in the control set (P < 0.05). Results are summarized in Table I.   Table I 720 + 60 1800 + 360 720 + 70 3900 + 1700 7200 + 2700 3600 + 1300 2700 + 500 1100 + 300 1500 + 300 900+100 1800 + 200 2200 + 400 820 + 240" 1 3200 + 500 3900 + 1700 10,000 + 4000 2700 + 500 1100 + 300 6400 + 1000 4000 + 1100
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•Sectors containing MAMA signals that were significantly higher (P < 0.05) than that of the background (see Figure 1) . b Mutants per sector = mutant fraction (+ standard deviation)X3.7xl0 7 cells/sector (also see Figure 1 ). Tvlutants per animal (+ standard deviation) represents the sum of mutants from all sector within a given animal. dimethylbenz [a] anthracene (DMBA)-induced lesions were shown to frequently harbor Ha-ras-1 oncogenes activated by CAA-CTA transversions in codon 61, whereas NMU-induced lesions harbored GGA-GAA mutation in codon 12 (16, 17) .
Analogous experiments carried out in vitro, utilizing well defined tissue culture conditions, produced strikingly different results. For example, transformed cell lines derived from DMBA-treated skin cells, initially selected for their ability to grow in the absence of epidermal growth factor did not contain the A to T mutation (18), whereas those derived from the same DMBA treated skin cells, initially selected for their ability to resist Ca 2+ -induced terminal differentiation, did harbor the A to T mutation (19, 20) . Furthermore, A-T mutations of the Ha-ras-1 gene were observed among transformants that were initially selected for their ability to resist Ca 2+ -induced terminal differentiation, whether they were treated with DMBA, MNNG or received no carcinogen treatment at all (20). These observations strongly suggest that the selection for Ha-ras-1 mutants was determined by the environment in which the cells were initially grown, regardless of the mutagenic specificity of the initiating carcinogen.
Tumorigenesis is a multistep process, which at least in part, is driven by the sequential acquisition of relevant mutations (21) . Our data support the hypothesis that whether or not a 
128 bp-74 bp- Fig. 3 . MAMA of spontaneously arising mammary lesions. The equivalent of -1.5X10 6 genome copies from each sample (5 u.g of generic DNA) was subjected to MAMA. At the same time, 1.5X10* copies of wild type genomic DNA were mixed with -15, 150 and 1500 copies of transforming allele from a NMU-induced mammary tumor genomic DNA, and subjected to MAMA as a quantitative control set. For the PCR efficiency control amplification, about -3X1O 5 copies (1 |ig) of each sample were subjected to 30 cycles of three-step PCR utilizing primers that will generate 128 bp fragment. The positions of the 74 bp mutant allele specific band and the 128 bp control amplification band are indicated by arrows on the Phospholmager generated autoradiogram. Every sample was assayed on at least two separate occasions, and ' + ' denotes those samples with a Ha-ras-1 mutant number that was significantly above the background (P < 0.05). Results are summarized in Table III. conditional oncomutation will contribute to mammary carcinogenesis is at least in part determined by physiological conditions existing in the host. Although our observations are also consistent with the notion that NMU selected for the preexisting Ha-ras-1 mutants by introducing a complementing mutation(s) in mutants, this possibility is remote given that there are only ~160 mammary epithelial cells with Ha-ras-1 mutations per animal at the time of exposure (6) . The highest reported NMU-induced mutation fraction is ~10" 4 using an in vitro assay (22) . If NMU selected for the mutants by inducing a mutation in a co-operating oncogene, then the expected incidence of NMU-induced mammary carcinomas with Ha-ras-1 mutations would be about one in 63 treated animals (one mutation in 10" 4 cells/ 160 cells per animal). Since the reported incidence of NMU-induced tumors with Ha-ras-1 oncogenes approaches 90% (10, 13, 14) it is much more likely that NMU selects for pre-existing, conditional Ha-ras-1 oncomutations via epigenetic mechanisms or by altering the physiological condition of the host.
